Delivery Order SPE2DE24D0021-SPE2D625F3NKF
- Not listed
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,076.64 on August 21, 2025, for the procurement of BinaxNow COVID-19 antigen testing kits. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and is funded by the Defense Department's Medical Supply Chain division. Performance will be completed in Pittsburgh, Pennsylvania, with an ultimate completion date of August 28, 2025. This award represents a child contract with no...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $2,205.00 for BinaxNow COVID-19 antigen OTC test kits (12 tests per 2-test case) by the Defense Medical Supply Chain federal agency. The contract, awarded on September 9, 2025, with an ultimate completion date of September 16, 2025, utilizes a fixed price with economic price adjustment pricing structure. The place of performance is Pittsburgh, Pennsylvania. This delivery order represents a child contract, indicating...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,176.00 on September 16, 2025, for the supply of BinaxNOW COVID-19 antigen testing kits to support the Medical Supply Chain program within the Department of Defense. The contract utilizes a fixed-price structure with economic price adjustment provisions and is scheduled for completion by September 23, 2025. As a child contract under a larger vehicle, this delivery order represents Fisher Scientific's role as a critical...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,176.00 on August 19, 2025, for the supply of BinaxNOW COVID-19 antigen testing kits. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 26, 2025, with performance taking place in Pittsburgh, Pennsylvania. The award was made without a set-aside designation, indicating open competition procurement. The funding agency is the Medical Supply Chain, operating under the...
- Fisher Scientific Company L.L.C. received a delivery order award on August 22, 2025, for the procurement of BinaxNOW COVID-19 antigen testing kits. The contract carries a ceiling value of $2,213.20 and is structured as a fixed-price agreement with economic price adjustment provisions. Funding originates from the Medical Supply Chain division within the Department of Defense. The place of performance is listed as Pittsburgh, PA. This delivery order represents a child contract, indicating it falls...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,897.80 on August 11, 2025, for the provision of BinaxNOW COVID antigen testing kits to support the Medical Supply Chain, a defense-oriented federal agency. This fixed-price delivery order with economic price adjustment capability represents a child contract under a larger vehicle and will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of August 18, 2025. No set-aside designation was applied...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,470.00 by the Defense Medical Supply Chain on August 19, 2025, for the supply of BinaxNOW COVID-19 antigen over-the-counter test kits (12 tests per box, 2 boxes per case). This fixed-price contract with economic price adjustment provisions represents a child contract under a larger vehicle and carries no set-aside designation. The order is scheduled for completion by August 26, 2025, with performance directed to...
- Fisher Scientific Company L.L.C. received a delivery order award valued at $3,920 for BinaxNow COVID-19 test kits under a fixed-price contract with economic price adjustment. The order, issued on September 16, 2025, with an ultimate completion date of September 23, 2025, will be performed in Pittsburgh, Pennsylvania. This is a child contract with no set-aside designation, awarded through open competition to support the Medical Supply Chain, a defense-focused federal agency function. Fisher...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,540.27 on August 4, 2025, for the procurement of BinaxNOW COVID-19 antigen testing kits. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and is scheduled for completion by August 11, 2025. Performance will take place in Pittsburgh, Pennsylvania. This award represents a child contract under a larger vehicle and was issued without a set-aside designation, reflecting...
- Fisher Scientific Company L.L.C. received a fixed-price delivery order contract from the Medical Supply Chain, a defense-focused federal agency, for the procurement of BinaxNOW COVID-19 antigen testing kits. The contract, valued at $2,156.00, was awarded on September 10, 2025, with an ultimate completion date of September 17, 2025. Performance will take place in Pittsburgh, Pennsylvania. This delivery order represents a child contract with no set-aside designation, awarded through open...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F3NKFDelivery Order
Fisher Scientific Company L.L.C. was awarded a delivery order contract for BinaxNow COVID-19 antigen testing kits on September 16, 2025, with a ceiling value of $1,960. The contract, issued by the Defense Medical Supply Chain, is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting open competition in the award process. Performance will be executed in Pittsburgh, Pennsylvania, with an ultimate completion date of September 23, 2025. This delivery order represents a child contract mechanism under a larger procurement vehicle, allowing the Medical Supply Chain to access Fisher Scientific's inventory of diagnostic testing solutions. As a major federal supplier of laboratory and medical equipment since 2001, Fisher Scientific maintains established relationships across numerous government agencies, including the Department of Veterans Affairs and the Department of Defense, positioning it as a critical vendor for diagnostic and testing initiatives. The relatively modest contract value of $1,960 indicates a spot purchase of testing kits to meet immediate operational requirements within the defense medical supply infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/16/25 |